Drug Profile
West Nile virus DNA vaccine - NIH/Fresh Tracks Therapeutics
Alternative Names: West Nile Virus vaccine - NIH/Fresh Tracks Therapeutics; WNV vaccine - NIH/Fresh Tracks TherapeuticsLatest Information Update: 14 Sep 2022
Price :
$50
*
At a glance
- Originator National Institutes of Health (USA); Vical
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported West Nile virus infections
Most Recent Events
- 07 Sep 2022 Brickell Biotech Inc is now called Fresh Tracks Therapeutics
- 31 Aug 2019 Brickell Biotech has merged with Vical to form Brickell Biotech Inc, and subsequently Brickell Biotech changed its name to Brickell Subsidiary
- 16 Jul 2016 No recent reports of development identified for phase-I development in West Nile virus infections(Prevention) in USA (Injection)